Monte Rosa Therapeutics (GLUE) Tax Provisions (2023 - 2026)
Monte Rosa Therapeutics (GLUE) recorded quarterly Tax Provisions of $52000.0 in Q1 2026, down 11.86% quarter-over-quarter from $59000.0 in Q4 2025, and down 93.67% on a YoY basis from $822000.0 in Q1 2025.
Monte Rosa Therapeutics (GLUE) Tax Provisions (2023 - 2026) Analysis & Trends
Monte Rosa Therapeutics' Tax Provisions history runs 4 years deep, the most recent figure standing at $52000.0 for Q1 2026.
- In Q1 2026, Tax Provisions fell 93.67% year-over-year to $52000.0; the TTM figure through Mar 2026 stood at -$1.9 million (down 156.42% YoY), while the FY2025 annual figure was -$1.1 million, down 142.68% from the prior year.
- Tax Provisions was $52000.0 for Q1 2026 at Monte Rosa Therapeutics, down from $59000.0 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $2.2 million in Q4 2024 to a low of -$3.2 million in Q3 2025.
- Historically, Tax Provisions has averaged $155250.0 across 4 years, with a median of $126500.0 in 2023.
- The sharpest annual moves came in 2024 and 2025: Tax Provisions surged 9936.36% in 2024, then slumped 4574.65% in 2025.
- A 4-year view of Tax Provisions shows it stood at -$22000.0 in 2023, then soared by 9936.36% to $2.2 million in 2024, then slumped by 97.27% to $59000.0 in 2025, then slipped by 11.86% to $52000.0 in 2026.
- The last three Tax Provisions figures came in at $52000.0 (Q1 2026), $59000.0 (Q4 2025), and -$3.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 216,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Monte Rosa Therapeutics | 1.83 Bn | 1.15 Bn | - | 52,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 52,000.00 |
| Dec 31, 2025 | 59,000.00 |
| Sep 30, 2025 | -3.18 Mn |
| Jun 30, 2025 | 1.20 Mn |
| Mar 31, 2025 | 822,000.00 |
| Dec 31, 2024 | 2.16 Mn |
| Sep 30, 2024 | 71,000.00 |
| Jun 30, 2024 | 252,000.00 |
| Mar 31, 2024 | 83,000.00 |
| Dec 31, 2023 | -22,000.00 |
| Sep 30, 2023 | 170,000.00 |
| Jun 30, 2023 | 190,000.00 |